Skip to main content
Log in

3D-QSAR studies and molecular docking on [5-(4-amino-1H-benzoimidazol-2-yl)-furan-2-yl]-phosphonic acid derivatives as fructose-1,6-biphophatase inhibitors

  • Published:
Journal of Computer-Aided Molecular Design Aims and scope Submit manuscript

Abstract

Fructose-1,6-biphophatase has been regarded as a novel therapeutic target for the treatment of type 2 diabetes mellitus (T2DM). 3D-QSAR and docking studies were performed on a series of [5-(4-amino-1H-benzoimidazol-2-yl)-furan-2-yl]-phosphonic acid derivatives as fructose-1,6-biphophatase inhibitors. The CoMFA and CoMSIA models using thirty-seven molecules in the training set gave r 2cv values of 0.614 and 0.598, r 2 values of 0.950 and 0.928, respectively. The external validation indicated that our CoMFA and CoMSIA models possessed high predictive powers with r 20 values of 0.994 and 0.994, r 2m values of 0.751 and 0.690, respectively. Molecular docking studies revealed that a phosphonic group was essential for binding to the receptor, and some key features were also identified. A set of forty new analogues were designed by utilizing the results revealed in the present study, and were predicted with significantly improved potencies in the developed models. The findings can be quite useful to aid the designing of new fructose-1,6-biphophatase inhibitors with improved biological response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14

Similar content being viewed by others

References

  1. Dang Q, Kasibhatla SR, Xiao W, Liu Y, DaRe J, Taplin F, Reddy KR, Scarlato GR, Gibson T, Poelje PD, Potter SC, Erion MD (2010) J Med Chem 53:441–451

    Article  CAS  Google Scholar 

  2. Kitas E, Mohr P, Kuhn B, Hebeisen P, Wessel HP, Haap W, Ruf A, Benz J, Joseph C, Huber W, Sanchez RA, Paehler A, Benardeau A, Gubler M, Schott B, Tozzo E (2010) Bioorg Med Chem Lett 20:594–599

    Article  CAS  Google Scholar 

  3. Heng S, Harris KM, Kantrowitz ER (2010) Eur J Med Chem 45:1478–1484

    Article  CAS  Google Scholar 

  4. Gizak A, Zarzycki M, Rakus D (2009) Biochi Et Bioph Act 1793:871–877

    Article  CAS  Google Scholar 

  5. Rudnitskaya A, Huynh K, Torok B, Stieglitz K (2009) J Med Chem 52:878–882

    Article  CAS  Google Scholar 

  6. Dang Q, Brown BS, Liu Y, Rydzewsky RM, Robinson ED, Poelje PD, Reddy MR, Erion MD (2009) J Med Chem 52:2280–2898

    Article  Google Scholar 

  7. Dang Q, Kasibhatla SR, Jiang T, Fan K, Liu Y, Taplin F, Schulz W, Cashion DK, Reddy KR, Poelje PD, Fujitake JM, Potter SC, Erion MD (2008) J Med Chem 51:4331–4339

    Article  CAS  Google Scholar 

  8. Heng S, Gryncel KR, Kantrowitz ER (2009) Bioorg Med Chem 17:3916–3922

    Article  CAS  Google Scholar 

  9. Hebeisen P, Kuhn B, Kohler P, Gubler M, Huber W, Kitas E, Schott B, Benz J, Joseph C, Ruf A (2008) Bioorg Med Chem Lett 18:4708–4712

    Article  CAS  Google Scholar 

  10. SYBYL 8.1, Tripos Inc., 1699 South Hanley Rd., St. Louis, Missouri, 63144, USA

  11. Lan P, Huang ZJ, Sun JR, Chen WM (2010) Int J Mol Sci 11:3357–3374

    Article  CAS  Google Scholar 

  12. Politi A, Durdagi S, Moutevelis-Minakakis P, Kokotos G, Papadopoulos MG, Mavromoustakos T (2009) Eur J Med Chem 44:3703–3711

    Article  CAS  Google Scholar 

  13. Chung JY, Chung HW, Cho SJ, Hah JM, Cho AE (2010) J Comput Aided Mol Des 24:385–397

    Article  CAS  Google Scholar 

  14. Liu HY, Liu SS, Qin LT, Mo LY (2009) J Mol Model 15:837–845

    Article  CAS  Google Scholar 

  15. Pan X, Tan N, Zeng G, Huang H, Yan H (2010) Eur J Med Chem 45:667–681

    Article  CAS  Google Scholar 

  16. Lu XY, Chen YD, You QD (2010) Chem Biol Drug Des 75:195–203

    Article  CAS  Google Scholar 

  17. Murumkar PR, Zambre VP, Yadav MR (2010) J Comput Aided Mol Des 24:143–156

    Article  CAS  Google Scholar 

  18. Tsukada T, Takahashi M, Takemoto T, Kanno O, Yamane T, Kawamura S, Nishi T (2010) Bioorg Med Chem 20:1004–1007

    Article  CAS  Google Scholar 

  19. Pasha FA, Muddassar M, Srivastava AK, Cho SJ (2010) J Mol Model 16:263–277

    Article  CAS  Google Scholar 

  20. Durdagi S, Mavromoustakos T, Papadopoulos MG (2008) Bioorg Med Chem Lett 18:6283–6289

    Article  CAS  Google Scholar 

  21. Golbraikh A, Tropsha A (2002) J Mol Graph Model 20:269–276

    Article  CAS  Google Scholar 

  22. Roy PP, Roy K (2008) QSAR Comb Sci 27:302–313

    Article  CAS  Google Scholar 

  23. Lu P, Wei X, Zhang R (2010) Eur J Med Chem 45:3413–3419

    Article  CAS  Google Scholar 

  24. Basu A, Jasu K, Jayaprakash V, Mishra N, Ojha P, Bhattacharya S (2009) Eur J Med Chem 44:2400–2407

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This research work is supported by “the Fundamental Research Funds for the Central Universities” (No. 21610405), China.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wei-Min Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lan, P., Xie, MQ., Yao, YM. et al. 3D-QSAR studies and molecular docking on [5-(4-amino-1H-benzoimidazol-2-yl)-furan-2-yl]-phosphonic acid derivatives as fructose-1,6-biphophatase inhibitors. J Comput Aided Mol Des 24, 993–1008 (2010). https://doi.org/10.1007/s10822-010-9391-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10822-010-9391-z

Keywords

Navigation